Skip to content
Disclosery

RHO CAPITAL PARTNERS INC

Follow

13F filer, CIK 1020455, NEW YORK, NY

RHO CAPITAL PARTNERS INC reported $154,070,000 across 5 holdings for the quarter ended 2021-12-31, in a 13F-HR filed 2022-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-22-000399

Period
2021-12-31
Reported value
$154M
Holdings
5
Top 10 weight
100%
New
1
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LIVEONE INCnew+3,724,137$4.77M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LIVEXLIVE MEDIA INCexited-3,724,137-$11.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2021

Share positions as resolved from 13F-HR 0001420506-22-000399, largest first. % of portfolio is the value over $154,070,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CHARGEPOINT HLDGS INCCHARGEPOINT HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 4,053,257 shares 4,053,257$77.2M50.12%0
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 3,766,666 shares 3,766,666$66.7M43.3%0
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 796,458 shares 796,458$4.95M3.22%0
LIVEONE INCLIVEONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 3,724,137 shares 3,724,137$4.77M3.09%new
SENSEONICS HLDGS INCSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: 159,601 shares 159,601$426K0.28%0

Sold out in Q4 2021

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LIVEXLIVE MEDIA INCLIVEXLIVE MEDIA INC3,724,137$11.1Mshares
ONTFON24 INC0$0shares
CARA THERAPEUTICS INCCARA THERAPEUTICS INC0$0shares

How Q4 2021 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-22-000399 base2022-02-14acceptance time not in the bulk data set